Capstone initiates Coverage on Inverness Medical Innovations (IMA) with a Buy
IMA Hot Sheet
Rating Summary:0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 24 | Down: 13 | New: 29
Capstone initiates coverage on Inverness Medical Innovations (NYSE: IMA) with a Buy. Price target $47.
To see more analyst ratings on IMA Click Here.
Inverness Medical Innovations, Inc. engages in the development, manufacture, and marketing of consumer and professional medical diagnostic products, as well as a range of vitamins and nutritional supplements
To see more analyst ratings on IMA Click Here.
Inverness Medical Innovations, Inc. engages in the development, manufacture, and marketing of consumer and professional medical diagnostic products, as well as a range of vitamins and nutritional supplements
You May Also Be Interested In
- UPDATE: UBS Starts Phillips 66 (PSX) at Buy; Valuation at Forefront
- Howard Weil Starts Phillips 66 (PSX) at Market Outperform
- Barclays Cut Price Target and Estimate on Advance Auto Parts (AAP); Company-Specific Issues
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
